GLP-1 analogues are an effective and groundbreaking method for weight loss, especially for those who struggle to control appetite and achieve long-term results through diet and exercise alone. These medications help reduce hunger and increase feelings of fullness, leading to a natural reduction in calorie intake.
At FagerCare, we offer GLP-1 analogues as part of our weight-loss program, aiming to support you in achieving a healthy and sustainable weight.
GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a vital role in regulating blood sugar and appetite. The hormone is released after meals and signals the pancreas to produce insulin, helping to lower blood sugar levels. GLP-1 also affects the brain’s satiety centers, reducing hunger and increasing feelings of fullness.
These effects make GLP-1 analogues effective for treating both type 2 diabetes and weight loss by helping the body naturally control blood sugar and appetite.
3,800 SEK/month at full dosage.
2,500 SEK/month at full dosage.
Testing GLP-1 treatment for overweight individuals can be an effective tool for those struggling to lose weight independently. GLP-1 analogues help reduce appetite and increase feelings of fullness by affecting the body’s natural hunger and satiety hormones, making it easier to maintain a reduced calorie intake. Additionally, GLP-1 supports blood sugar control, which is particularly beneficial for individuals with insulin resistance or type 2 diabetes, conditions often linked to being overweight. For many, the treatment offers an opportunity to create long-term changes in diet and lifestyle, achieving a healthy weight with the support of a scientifically proven method.
At FagerCare, we include GLP-1 as part of our weight-loss treatment program and help you create a long-term plan for achieving a healthy weight and improving your quality of life with our expert support.
BMI is a practical tool to estimate whether your weight is within a healthy range in relation to your height. By using a simple formula (your weight divided by your height squared in meters), BMI can indicate if you are underweight, of normal weight, overweight or obese.
Our medications are recommended for individuals with obesity (a BMI of 30 or higher) or overweight (BMI between 27 and 30) where complications or risk factors exist, such as high blood pressure, elevated cholesterol, high blood sugar, atherosclerosis or sleep apnea.
“I have tried many methods to lose weight, but with FagerCare, I finally saw results. With their advice, I’ve received both support and tools that truly worked for me.”
- Patrik Sturesson
“Semaglutide has truly made a difference for me. I’ve lost weight in a way that feels sustainable and regained both energy and motivation. It feels like a life-changing transformation I can finally hold onto!”
- Tobias Larsson
“I’ve finally started seeing results that feel sustainable and inspiring. I haven’t just lost weight but also feel much more energetic and happier in daily life.”
- Sofia Bäck
We’ve compiled the most common questions about GLP-1 to make it easy for you to find the answers you’re looking for. If you have any additional questions or concerns that are not covered here, please do not hesitate to contact us – we are here to help and answer all your questions.
GLP-1 analogues work for weight loss by mimicking the body’s natural GLP-1 hormone, which plays a key role in regulating appetite and blood sugar. When GLP-1 analogues are taken, they affect the brain’s satiety centers, making you feel full faster and reducing your appetite, helping lower calorie intake. Additionally, GLP-1 analogues delay gastric emptying, which prolongs feelings of fullness after meals. The treatment also has a positive effect on blood sugar levels by stimulating insulin release when needed, which is particularly beneficial for people with type 2 diabetes or insulin resistance.
The most effective GLP-1 analogues for weight loss are Semaglutide (Wegovy) and Liraglutide (Saxenda). Semaglutide is taken as a weekly injection and has been shown to produce significant weight loss, with an average reduction of approximately 15% over one year. Liraglutide is used daily via injection and achieves an average weight loss of 5–7% over a year. Both Semaglutide and Liraglutide help reduce appetite and increase satiety, supporting sustainable weight loss.
Copyright © 2024 FagerCare
Produced by Searchminds